Ypsomed Holding AG (0QLQ.L) LSE

335.80

+0.1914(+0.06%)

Updated at June 03 08:10AM

Currency In CHF

Ypsomed Holding AG

Address

Brunnmattstrasse 6

Burgdorf, 3401

Switzerland

Phone

41 34 424 41 11

Sector

Healthcare

Industry

Medical - Devices

Employees

2600

First IPO Date

May 19, 2016

Key Executives

NameTitlePayYear Born
Simon MichelCEO, Member of Executive Board & Member of the Board1.1M1977
Frank MengisCOO, Deputy CEO Member of Executive Board01964
Nicolas MeyerChief Legal Officer & Secretary and Member of Executive Board01971
Samuel KunzliChief Financial Officer & Member of Executive Board01984
Ulrike BauerChief Business Officer & Member of Executive Board01969
Sam GhezelbashHead of Investor Relations & M&A0N/A
Michael ZauggChief Corporate Officer & Member of Executive Board01972

Description

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.